BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7036102)

  • 1. [Broncholytic effect of salbutamol, ventolin and berotec aerosols in bronchial asthma].
    Jagodziński J; Woźniakowska U
    Pneumonol Pol; 1981; 49(10):695-701. PubMed ID: 7036102
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of bronchodilator and extrabronchial action of salbutamol Polfa-aerosol in comparison with Ventolin Pliva, Berotec Boehringer Ingelheim and Astmopent Polfa in patients with chronic obstructive bronchitis.
    Roźniecki J; Gondorowicz K; Szmidt M; Grabski W
    Mater Med Pol; 1978; 10(2):139-45. PubMed ID: 703389
    [No Abstract]   [Full Text] [Related]  

  • 3. [New aspects of using adrenomimetics in the diagnosis and treatment of bronchial asthma].
    Solopov VN; Lunichkina IV
    Klin Med (Mosk); 1991 Feb; 69(2):55-8. PubMed ID: 1875664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the protective action of Salbutamol Polfa--aerosol in relation to histamine induced bronchospasm in patients with bronchial asthma, in comparison with the effect of Ventolin-Pliva, Astmopent-Polfa and Berotec-Boehringer.
    Rozniecki J; Szmidt M; Grabski W; Gondorowicz K
    Mater Med Pol; 1977; 9(4):331-5. PubMed ID: 599965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bronchodilator effect of aerosol salbutamol in infantile bronchial asthma].
    Miraglia del Giudice M; Tomasi L; Ferrara M
    Pediatria (Napoli); 1974 Mar; 82(1):48-64. PubMed ID: 4603371
    [No Abstract]   [Full Text] [Related]  

  • 6. Fenoterol versus salbutamol nebuliser solution in asthma.
    Hockley B; Johnson NM
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():543-5. PubMed ID: 6352317
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of oral tulobuterol on bronchial obstruction in asthmatic patients].
    Vergeret J; Taytard A
    Therapie; 1988; 43(1):21-4. PubMed ID: 3358248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Study of the delay of action of an injected corticoid on bronchial obstruction in asthmatics. Comparison with an inhaled beta-stimulating agent].
    Arnaud A; Orehek J; Autran P; Tricard P; Charpin J
    Nouv Presse Med; 1975 Apr; 4(16):1211. PubMed ID: 1099541
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of inhaled fenoterol and salbutamol in the prevention of exercise-induced asthma.
    Sturani C; Schiavina M; Tosi I; Gunella G
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():526-8. PubMed ID: 6352313
    [No Abstract]   [Full Text] [Related]  

  • 10. Aerosolised bronchodilator therapy with & without IPPR in bronchial asthma--a comparative evaluation.
    Gupta S; Poddar SP; Nath S
    Indian J Chest Dis Allied Sci; 1978 Jul; 20(3):118-25. PubMed ID: 363611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of berotec electrophoresis in the treatment of children with bronchial asthma].
    Bespal'ko NN; Karachevtseva TV; Reviakina VA; Reutova VS; Kotsaga VE; Markov BA; Reshetniak VIu
    Pediatriia; 1990; (1):77-80. PubMed ID: 1970432
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
    Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
    J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of treatment with ventolin and becotide on ventilation and hemodynamics in patients with bronchial asthma].
    Sil'vestrov VP; Surovov IuA; Pakulin IA; Larin NV
    Klin Med (Mosk); 1983 Dec; 61(12):54-8. PubMed ID: 6366358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of different broncholytic aerosols on the peak expiratory flow rate in asthmatic patients].
    Mattila M; Muittari A
    Duodecim; 1966; 82(9):423-9. PubMed ID: 5326760
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double blind test with hexoprenaline (Ipradol)-dosage-aerosol apparatus in bronchial asthma].
    Dübi B; Studer A; Scherrer M
    Schweiz Med Wochenschr; 1974 Jun; 104(23):827-31. PubMed ID: 4601410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
    Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
    Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of asthma with salbutamol aerosol.
    Freisleben RL
    Postgrad Med J; 1971 Mar; 47():Suppl:82-3. PubMed ID: 4929398
    [No Abstract]   [Full Text] [Related]  

  • 18. [Broncholytic effect of pencardin in chronic bronchial asthma].
    Bestry-Fus I
    Pneumonol Pol; 1981 Jan; 49(1):43-7. PubMed ID: 7027193
    [No Abstract]   [Full Text] [Related]  

  • 19. PHARMAC and Ventolin in New Zealand.
    Gillies J; Brown J; Byrnes C; Farrell A; Graham D
    N Z Med J; 2005 Aug; 118(1220):U1616. PubMed ID: 16132077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoterol administered as an inhaled powder. A comparison with salbutamol powder.
    Hey AA; Gillies AJ
    N Z Med J; 1985 Feb; 98(772):74-5. PubMed ID: 3883254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.